⟵ Back to Search Results
BGB-A317-207

Completed

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

Beigene Study ID info

BGB-A317-207

ClinicalTrials.gov ID info

NCT03493451

EudraCT Number info

2017-003700-44

China Drug Trials ID info

CTR20171387

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan